PHILADELPHIA, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC, founded in 2012, is a mid-sized nonprofit in the Diseases & Disorders sector that reported $53.3M in total revenue in fiscal year 2024.
THE PURPOSE OF ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC. IS TO FOSTER CLINICAL RESEARCH WITHIN THE PUBLIC, NON-PROFIT AND PRIVATE SECTORS FOR THE DETECTION, DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND OTHER RELATED DISEASES, INCLUDING THROUGH DEVELOPING TECHNOLOGY TO PREDICT PROGNOSIS AND RESPONSES TO THERAPEUTIC INTERVENTION FOR PATIENTS WITH CANCER AND OTHER RELATED DISEASES, THAT WILL ULTIMATELY IMPROVE THE OUTCOMES FOR CANCER PATIENTS.
FEDERAL GRANTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS FEDERAL FUNDING, BOTH DIRECT AND AS A SUBRECIPIENT, SUPPORTS THE EFFORTS OF THE NCI TO IMPROVE OUTCOMES FOR CANCER...
FEDERAL GRANTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS FEDERAL FUNDING, BOTH DIRECT AND AS A SUBRECIPIENT, SUPPORTS THE EFFORTS OF THE NCI TO IMPROVE OUTCOMES FOR CANCER PATIENTS. THIS FEDERAL FUNDING AIDS ECOG- ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS. IN ADDITION, THE FUNDS ARE USED TO PROMOTE COLLABORATION ACROSS A PROLIFIC SCIENTIFIC COMMUNITY AND TO CONTINUE THE STRONG ENGAGEMENT OF PATIENT ADVOCACY AT ALL LEVELS.
PHARMACEUTICAL GRANTS THROUGH SUPPLEMENTAL FUNDING ON NCI APPROVED AND FUNDED TRIALS, ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. CARRIES OUT ACTIVITIES DESCRIBED IN THE SCOPE OF FUNCTIONS OF EACH...
PHARMACEUTICAL GRANTS THROUGH SUPPLEMENTAL FUNDING ON NCI APPROVED AND FUNDED TRIALS, ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. CARRIES OUT ACTIVITIES DESCRIBED IN THE SCOPE OF FUNCTIONS OF EACH NCI PROTOCOL. ALL FUNCTIONS ARE PERFORMED IN COMPLIANCE WITH FEDERAL, STATE AND LOCAL LAWS, WITH AN OVERARCHING GOAL OF REACHING FULL ACCRUALS TO FURTHER ADVANCE THE RESEARCH AND MEDICINE AIMED AT IMPROVING OUTCOMES FOR CANCER PATIENTS.
FEDERAL CONTRACTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS SUBRECIPIENT FEDERAL CONTRACT FUNDING FOR THE NCI MATCH AND MDS PROGRAMS AIDS ECOG-ACRIN IN PROVIDING THE SUPPORT...
FEDERAL CONTRACTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS SUBRECIPIENT FEDERAL CONTRACT FUNDING FOR THE NCI MATCH AND MDS PROGRAMS AIDS ECOG-ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT SPECIFIC RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT THE PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $53,346,165 | $52,804,335 | +0.0% |
| Expenses | $53,483,722 | $52,712,275 | +0.0% |
| Net Income | $-137,557 | $92,060 | -2.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DANIEL BARBORIAK MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| AL BOWEN BENSON MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| PATRICK FLYNN MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| STANLEY M HAMILTON MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| BARRY A SIEGEL MD | BOARD MEMBER | N/A |
Director
|
$0 | $0 | $0 |
| MITCHELL SCHNALL MD PHD | SECRETARY/TR | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| PETER O'DWYER MD | PRESIDENT | 15.00 |
Officer
Director
|
$0 | $0 | $0 |
| DONNA MARINUCCI | EXECUTIVE DI | 40.00 |
Officer
|
$304,916 | $13,195 | $318,111 |
| JEAN MACDONALD | DEPUTY EXEC | 40.00 |
Highest
|
$271,847 | $36,376 | $308,223 |
| KENNETH ROCKWELL | DIR REGULATO | 40.00 |
Highest
|
$222,411 | $38,976 | $261,387 |
| PAMELA COGLIANO | DIRECTOR OF | 40.00 |
Highest
|
$198,544 | $34,397 | $232,941 |
| KERRY HIGGINS | DIRECTOR DAT | 40.00 |
Highest
|
$214,110 | $35,410 | $249,520 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $53,346,165 | $53,483,722 | $15,999,632 | $-137,557 |
| 2023 | $52,804,335 | $52,712,275 | $19,072,184 | $92,060 |
| 2022 | $47,611,416 | $47,501,599 | $17,592,395 | $109,817 |
| 2021 | $49,270,427 | $48,907,395 | $11,624,125 | $363,032 |
| 2020 | $42,828,537 | $42,644,697 | $13,431,417 | $183,840 |
| 2019 | $33,841,613 | $33,773,586 | $10,263,240 | $68,027 |
| 2018 | $36,956,875 | $36,719,372 | $11,169,804 | $237,503 |
Compare ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC with other nonprofits in Pennsylvania and across the country.